Trospium Chloride in the Treatment of Overactive Bladder Syndrome and Detrusor Overactivity. [PDF]
Truzzi JC, Sartori MGF, Kemp VL.
europepmc +1 more source
Anticholinergic burden and comorbidities in patients attending treatment with trospium chloride for overactive bladder in a real-life setting: results of a prospective non-interventional study. [PDF]
Ivchenko A +3 more
europepmc +1 more source
From theory to therapy: unlocking the potential of muscarinic receptor activation in schizophrenia with the dual M1/M4 muscarinic receptor agonist xanomeline and trospium chloride and insights from clinical trials. [PDF]
Meyer JM +4 more
europepmc +1 more source
Adherence to Oral Therapy for Urgency Urinary Incontinence: Results from the Anticholinergic Versus Botox Comparison (ABC) Trial. [PDF]
Visco AG +12 more
europepmc +1 more source
Long-term safety and efficacy of antimuscarinic add-on therapy in patients with overactive bladder who had a suboptimal response to mirabegron monotherapy: A multicenter, randomized study in Japan (MILAI II study). [PDF]
Yamaguchi O +13 more
europepmc +1 more source
Target-independent prediction of drug synergies using only drug lipophilicity. [PDF]
Yilancioglu K +9 more
europepmc +1 more source
Trospium and cognition in patients with late onset Alzheimer disease. [PDF]
Isik AT +4 more
europepmc +1 more source
Brain penetration of the OAB drug trospium chloride is not increased in aged mice. [PDF]
Kranz J, Petzinger E, Geyer J.
europepmc +1 more source
Effect of anticholinergic use for the treatment of overactive bladder on cognitive function in postmenopausal women. [PDF]
Geller EJ +10 more
europepmc +1 more source
Superiority of pulmonary administration of mepenzolate bromide over other routes as treatment for chronic obstructive pulmonary disease. [PDF]
Tanaka K +11 more
europepmc +1 more source

